Who has invested in Alterome Therapeutics?

Goldman Sachs Alternatives, OrbiMed, Canaan Partners, Nextech Invest, Vida Ventures, Boxer Capital are named among the investors backing Alterome Therapeutics.

Alterome Therapeutics Funding: $231M Raised, Series A (2022)

Alterome Therapeutics funding overview

Alterome Therapeutics is a Biotech company based in San Diego. Alterome Therapeutics has raised $231M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in January 2022. The round record for Alterome Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include Goldman Sachs Alternatives, OrbiMed, Canaan Partners, Nextech Invest, Vida Ventures, Boxer Capital and 7 others. 13 distinct backers are named across the disclosed rounds.

Alterome Therapeutics at a glance

Total raised: $231M
Latest round: Series A
Latest round date: January 2022
Industry: Biotech
Headquarters: San Diego
Notable investors: Goldman Sachs Alternatives, OrbiMed, Canaan Partners, Nextech Invest, Vida Ventures, Boxer Capital, Andera Partners, VenBio Partners

Frequently asked about Alterome Therapeutics funding

How much has Alterome Therapeutics raised?: Alterome Therapeutics has raised $231M in total disclosed funding across the rounds on record.
Who has invested in Alterome Therapeutics?: Goldman Sachs Alternatives, OrbiMed, Canaan Partners, Nextech Invest, Vida Ventures, Boxer Capital are named among the investors backing Alterome Therapeutics.
What was the latest Alterome Therapeutics funding round?: The most recent disclosed round is a Series A, announced in January 2022.
Where is Alterome Therapeutics based?: Alterome Therapeutics is based in San Diego.
What sector does Alterome Therapeutics operate in?: Alterome Therapeutics is tracked under Biotech from San Diego, with $231M in disclosed funding.
When did Alterome Therapeutics last raise?: The last disclosed Alterome Therapeutics round closed in January 2022 at Series A.

Every Alterome Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies in San Diego at a similar stage.

Alterome Therapeutics Funding: $231M Raised, Series A (2022)

Alterome Therapeutics funding overview

Alterome Therapeutics at a glance

Frequently asked about Alterome Therapeutics funding

Companies related to Alterome Therapeutics (40)

Browse related funding lists (10)